Does BREXPIPRAZOLE Cause Psychomotor hyperactivity? 51 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Psychomotor hyperactivity have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.4% of all adverse event reports for BREXPIPRAZOLE.
51
Reports of Psychomotor hyperactivity with BREXPIPRAZOLE
0.4%
of all BREXPIPRAZOLE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From BREXPIPRAZOLE?
Of the 51 reports, 5 (9.8%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
Yes, Psychomotor hyperactivity is listed as a known adverse reaction in the official FDA drug label for BREXPIPRAZOLE.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which BREXPIPRAZOLE Alternatives Have Lower Psychomotor hyperactivity Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE